<?xml version="1.0" encoding="UTF-8"?>
<p id="p0280">There is increasing interest in novel approaches to treatment that simplify current guidelines, as was the case with hepatitis C(74), and obviate the need for complex and expensive testing to determine treatment eligibility, such as a “test and treat-all” approach(75). Whilst such an approach has not yet been explored in a clinical trial, a novel pilot study evaluating the cost-effectiveness and affordability of such an approach is currently underway in Uzbekistan (
 <xref rid="bib75" ref-type="bibr">75</xref>).
</p>
